Hong Kong, China vs Kyrgyzstan: New cases tested for RR-/MDR-TB
Hong Kong, China
96.0%
in 2024
Kyrgyzstan
96.0%
in 2024
Hong Kong, China rank
67th
Kyrgyzstan rank
67th
New cases tested for RR-/MDR-TB over time
- Hong Kong, China
- Kyrgyzstan
How they compare
Hong Kong, China currently reports 96.0% against 96.0% in Kyrgyzstan, a difference of 0.0%.
The two have swapped places 3 times across 16 shared years of data; in 2005 it was Hong Kong, China ahead.
Hong Kong, China ranks 67th and Kyrgyzstan ranks 67th of 192 countries.
Hong Kong, China has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Hong Kong, China | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 81.0% | 32.5% | 48.5% | Hong Kong, China |
| 2010s | 87.6% | 84.3% | 3.3% | Hong Kong, China |
| 2020s | 95.6% | 94.8% | 0.8% | Hong Kong, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Hong Kong, China or Kyrgyzstan?
- Hong Kong, China, at 96.0% against 96.0% in Kyrgyzstan as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Hong Kong, China and Kyrgyzstan?
- 0.0%, with Hong Kong, China ahead.
- How many years of comparable data are there for Hong Kong, China and Kyrgyzstan?
- 16 years are reported by both, from 2005 to 2024.
- How do Hong Kong, China and Kyrgyzstan rank globally for new cases tested for rr-/mdr-tb?
- Hong Kong, China ranks 67th and Kyrgyzstan ranks 67th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.